U.S. Military Expands Production of ‘Low-Dead Space’ Syringes

May 25, 2021 by Daniel Mollenkamp
U.S. Military Expands Production of ‘Low-Dead Space’ Syringes
CFAY conducts COVID-19 vaccinations for 12 to 17-year-olds (Photo by Tetsuya Morita Commander, Fleet Activities Yokosuka)

The Pentagon signed an agreement to expand the production of more efficient syringes, which it announced on Monday, as part of the country’s national response to coronavirus. 

According to the agreement, the U.S. allocated $27.3 million in government funding to Retractable Technologies, Inc., a manufacturer that has previously received government contracts to keep up with demand for needles because of the coronavirus outbreak. 

With that funding, Retractable will install two new automated assembly lines at its manufacturing facility based in Little Elm, Texas, the U.S. Department of Defense said.

The addition of these two assembly lines will expand the U.S.’s capacity to produce “low-dead” space syringes by 75%, according to a written comment from the DOD.

Low-dead space safety syringes are designed to lower the amount of “dead” or empty space between the syringe and the needle, allowing for more doses of a vaccine by preventing inaccurate dosing and waste. 

The U.S. Food and Drug Administration updated the authorization for Pfizer-BioNTech’s COVID-19 vaccine in January to allow physicians to extract six doses per vial rather than five, after they discovered that low-dead space syringes prevented enough waste to get another dose out of the vials, according to reporting from Physician’s Weekly.

The Pentagon has said that using LDS syringes will allow access to 20% more coronavirus vaccine doses than non-LDS syringes. 

The effort is part of the department’s attempt to both increase the availability of vaccines and the willingness of military personnel to get the vaccine.

A memo from last week reaffirmed the Pentagon’s support for initiatives to increase vaccination acceptance among all service members. 

That memo described coronavirus as “the greatest proximate challenge to our nation’s security,” and says that the department is moving to a “new phase” of its efforts now that it has an available supply of vaccines.

The memo instructs commanders that the vaccine is available to “all eligible beneficiaries,” and it outlines a plan for an “aggressive effort to inform and educate” about the vaccine.

It also suggests that leaders offer incentives to get the vaccine and asks them to hold “nonjudgmental” conversations to acknowledge the concerns of those who are hesitant about vaccines. 

“These conversations are not easy,” reads the memo, “they may not be short, and they may require multiple touchpoints, but they are critically important.”

“We know from our experience within the department that use of this approach works, and encourage its widespread adoption,” the DOD said.

All defense personnel became eligible to receive the coronavirus vaccine earlier this year. Reporting from April suggested that nearly a third, and in some cases perhaps more, of military personnel had opted out of getting the vaccine and there was even a question circulating about whether coronavirus vaccination should be made mandatory for the military. 

Military officials told reporters that the declinations of the vaccine came mostly from young and healthy service members who did not feel they needed a vaccine. Receiving a vaccine remains voluntary for service persons, according to the latest memo. 

However, vaccination rates in the military have increased since then as the military and some individual bases have looked to incentivize opting-in to the vaccine.

According to the latest data from the Centers for Disease Control, the DOD has administered 3,517,706 coronavirus vaccine doses. 

A+
a-
  • low-dead space syringes
  • medical
  • military
  • syringes
  • In The News

    Health

    Voting

    Health

    December 8, 2023
    by Dan McCue
    FDA Approves a CRISPR-Based Medicine to Treat Sickle Cell Disease

    WASHINGTON — The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology for... Read More

    WASHINGTON — The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology for the treatment of sickle cell disease. The new treatment, called Casgevy, was manufactured by Vertex Pharmaceuticals, of Boston, Massachusetts, and CRISPR Therapeutics, of Switzerland, using a... Read More

    Chronic Fatigue Syndrome More Common Than Past Studies Suggest, CDC Says

    NEW YORK (AP) — Health officials on Friday released the first nationally representative estimate of how many U.S. adults have... Read More

    NEW YORK (AP) — Health officials on Friday released the first nationally representative estimate of how many U.S. adults have chronic fatigue syndrome: 3.3 million. The Centers for Disease Control and Prevention's number is larger than previous studies have suggested, and is likely boosted by some... Read More

    December 8, 2023
    by Tom Ramstack
    White House Threatens to Penalize Pharma Companies for High Prices

    WASHINGTON — The Biden administration announced a plan Thursday to lower prescription drug costs in a move that takes a... Read More

    WASHINGTON — The Biden administration announced a plan Thursday to lower prescription drug costs in a move that takes a tough stance toward pharmaceutical companies charging high prices. If the Federal Trade Commission determines the prices are unreasonable, the new policy allows the federal government to... Read More

    December 6, 2023
    by Dan McCue
    House Unanimously Passes Bill to Increase Mental Health Resources for Veterans’ Caregivers

    WASHINGTON — The House on Monday unanimously passed the Caregiver Outreach and Program Enhancement Act, which would increase mental health... Read More

    WASHINGTON — The House on Monday unanimously passed the Caregiver Outreach and Program Enhancement Act, which would increase mental health resources available to caregivers of America’s veteran population. Alternately known as the COPE Act, the bipartisan legislation sponsored by Reps. Chrissy Houlahan, D-Pa., and Jen Kiggans,... Read More

    December 6, 2023
    by Dan McCue
    HHS Unveils Next Steps to Enhance Cybersecurity of Health Care Records

    WASHINGTON — The bad guys in cyberspace want your health care records.  Between 2018 and 2022, there was a 93%... Read More

    WASHINGTON — The bad guys in cyberspace want your health care records.  Between 2018 and 2022, there was a 93% increase in large breaches in the health care sector, with a 278% increase in large breaches involving ransomware, according to the Department of Health and Human... Read More

    December 6, 2023
    by Dan McCue
    New Report Sheds Some Light on Rare Post-COVID Shot Syndrome

    NEW HAVEN, Conn. — A study from the Yale School of Medicine sheds some new light on the rare, but... Read More

    NEW HAVEN, Conn. — A study from the Yale School of Medicine sheds some new light on the rare, but chronic and debilitating condition some people report experiencing after getting a COVID-19 vaccination. The paper, which was posted on the preprint server medRxiv and has not... Read More

    News From The Well
    scroll top